We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$47B
AUM Growth
+$127M
(+0.27%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
15.6%
Holding
2,719
New
139
Increased
718
Reduced
1,605
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$278M |
| 2 |
Amphenol
APH
|
+$213M |
| 3 |
Baxter International
BAX
|
+$193M |
| 4 |
Hilton Worldwide
HLT
|
+$189M |
| 5 |
Altria Group
MO
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetApp
NTAP
|
+$302M |
| 2 |
Ameriprise Financial
AMP
|
+$286M |
| 3 |
Dollar Tree
DLTR
|
+$268M |
| 4 |
Union Pacific
UNP
|
+$255M |
| 5 |
Lam Research
LRCX
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.01% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 13.35% |
| 4 | Financials | 12.43% |
| 5 | Industrials | 11.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1451
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $887K | ﹤0.01% |
19,626
+2,949
| +18% | +$134K |
|
1452
Kulicke & Soffa
KLIC
$5.01B
| $885K | ﹤0.01% |
37,166
+26,321
| +243% | +$625K |
|
1453
HEICO Corp
HEI
$51.9B
| $883K | ﹤0.01% |
12,102
-1,762
| -13% | -$128K |
|
1454
Trustmark
TRMK
$2.8B
| $883K | ﹤0.01% |
27,070
-1,078
| -4% | -$34.7K |
|
|
TEN
1455
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $882K | ﹤0.01% |
20,053
-1,366
| -6% | -$65.8K |
|
1456
ScottsMiracle-Gro
SMG
$3.59B
| $875K | ﹤0.01% |
10,525
-4,364
| -29% | -$365K |
|
1457
NovoCure
NVCR
$2.02B
| $874K | ﹤0.01% |
27,930
+1,814
| +7% | +$50.5K |
|
|
SAFM
1458
DELISTED
Sanderson Farms Inc
SAFM
| $873K | ﹤0.01% |
8,304
-467
| -5% | -$50.7K |
|
1459
Amneal Pharmaceuticals
AMRX
$6.02B
| $872K | ﹤0.01% |
+53,119
| New | +$932K |
|
1460
LCI Industries
LCII
$2.6B
| $870K | ﹤0.01% |
9,647
-894
| -8% | -$83K |
|
1461
Haverty Furniture Companies
HVT
$450M
| $868K | ﹤0.01% |
40,206
-1,147
| -3% | -$22.9K |
|
1462
AMC Global Media
AMCX
$496M
| $867K | ﹤0.01% |
13,940
-3,854
| -22% | -$220K |
|
|
SINA
1463
DELISTED
Sina Corp
SINA
| $866K | ﹤0.01% |
10,224
+2,777
| +37% | +$258K |
|
|
MDRX
1464
DELISTED
Veradigm Inc. Common Stock
MDRX
| $865K | ﹤0.01% |
72,049
-7,140
| -9% | -$88K |
|
|
PERY
1465
DELISTED
Perry Ellis International Inc
PERY
| $865K | ﹤0.01% |
31,830
-933
| -3% | -$25K |
|
1466
Huazhu Hotels Group
HTHT
$12.5B
| $863K | ﹤0.01% |
+20,564
| New | +$821K |
|
1467
Murphy USA
MUSA
$10.4B
| $862K | ﹤0.01% |
11,599
+3,139
| +37% | +$217K |
|
|
NUAN
1468
DELISTED
Nuance Communications, Inc.
NUAN
| $860K | ﹤0.01% |
71,518
-207,836
| -74% | -$2.58M |
|
1469
Ormat Technologies
ORA
$6.98B
| $858K | ﹤0.01% |
16,136
-1,688
| -9% | -$92.2K |
|
|
ARI
1470
Apollo Commercial Real Estate
ARI
$886M
| $856K | ﹤0.01% |
46,840
+3,246
| +7% | +$59.5K |
|
1471
Franklin Electric
FELE
$4.68B
| $855K | ﹤0.01% |
18,948
-1,566
| -8% | -$69.9K |
|
1472
Renasant Corp
RNST
$4B
| $855K | ﹤0.01% |
18,783
-293
| -2% | -$13.6K |
|
1473
AerCap
AER
$23.5B
| $851K | ﹤0.01% |
15,723
+478
| +3% | +$25.7K |
|
1474
AGCO
AGCO
$6.96B
| $851K | ﹤0.01% |
14,022
-3,602
| -20% | -$230K |
|
1475
Liberty Latin America Class C
LILAK
$1.65B
| $850K | ﹤0.01% |
+51,250
| New | +$895K |
|
Similar funds
VOYA Investment Management's Q2 2018 Portfolio in Review
As of Q2 2018, VOYA Investment Management held 2,719 positions worth $47B, up 0.27% from $46.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
VOYA Investment Management withdrew a net $1.58B in Q2 2018, closing 117 positions and reducing 1,605 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, VOYA Investment Management opened a new position in Jazz Pharmaceuticals worth $70.2M.
- VOYA Investment Management's largest Q2 2018 buy was Jazz Pharmaceuticals: 407,520 shares worth $70.2M.
- VOYA Investment Management added most to Alphabet (Google) Class A in Q2 2018, an estimated $278M increase.
- VOYA Investment Management's biggest Q2 2018 reduction was NetApp, cutting an estimated $302M.
- VOYA Investment Management fully exited iShare MSCI Eurozone ETF in Q2 2018, selling an estimated $111M.
- VOYA Investment Management's ten largest holdings make up 16% of its $47B portfolio in Q2 2018.
- VOYA Investment Management opened 139 new positions and closed 117 in Q2 2018.
- VOYA Investment Management's portfolio value rose 0.27% quarter-over-quarter to $47B.
Based on VOYA Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.